Article info

Download PDFPDF

Response to: ‘Dupilumab as a potential steroid-sparing treatment for IgG4-related disease’ by Della-Torre et al
Free

Authors

  1. Correspondence to Ms Rachel S Simpson, Toronto Allergists, Toronto, M5G 1E2, Canada; rachel.simpson{at}queensu.ca
View Full Text

Citation

Simpson RS, Lee JK
Response to: ‘Dupilumab as a potential steroid-sparing treatment for IgG4-related disease’ by Della-Torre et al

Publication history

  • Received January 24, 2020
  • Accepted January 27, 2020
  • First published February 7, 2020.
Online issue publication 
January 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.